Long Noncoding RNAs in Gastrointestinal Cancer: Tumor Suppression Versus Tumor Promotion
- 17 March 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 66 (2), 381-397
- https://doi.org/10.1007/s10620-020-06200-x
Abstract
Approximately 80% of the human genome harbors biochemical marks of active transcription that its majority transcribes to noncoding RNAs, namely long noncoding RNAs (lncRNAs). LncRNAs are heterogeneous RNA transcripts that regulate critical biological processes such as cell survival and death. They involve in the progression of different cancers by affecting transcriptional and post-transcriptional modifications as well as epigenetic control of numerous tumor suppressors and oncogenes. Recent findings show that aberrant expression of lncRNAs is associated with tumor initiation, progression, invasion, and overall survival of patients with gastrointestinal (GI) cancers. Some lncRNAs play as tumor suppressors in all GI cancers, but others play as tumor promoters. However, some other lncRNAs might function as a tumor suppressor in one GI cancer, but as a tumor promoter in another GI cancer type. This fact highlights possible context dependency of the expression patterns and roles of at least some lncRNAs in GI cancer development and progression. Here, we review the functional relation of lncRNAs involved in the development and progression of GI cancer by focusing on their roles as tumor suppressor and tumor promoter genes.Keywords
This publication has 149 references indexed in Scilit:
- Long non-coding RNA expression profile in human gastric cancer and its clinical significancesJournal of Translational Medicine, 2013
- Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- Landscape of transcription in human cellsNature, 2012
- RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usageNucleic Acids Research, 2011
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cellsBiochemical and Biophysical Research Communications, 2011
- Oncogenes and Tumor Suppressor GenesCold Spring Harbor Perspectives in Biology, 2010
- KIAA0495/PDAM Is Frequently Downregulated in Oligodendroglial Tumors and Its Knockdown by siRNA Induces Cisplatin Resistance in Glioma CellsBrain Pathology, 2010
- 5-Fluorouracil: Mechanisms of Resistance and Reversal StrategiesMolecules, 2008
- The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24Molecular Cancer Research, 2008